secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001140361-23-025873
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics to fill Class I director vacancy by Dec 31, 2023 with candidate meeting Nasdaq diversity criteria
--------------------------------------------------------------------------------

- After Annual Meeting and re-election of Bryant Fong, a Class I director vacancy will exist.
- Board intends to fill vacancy with a candidate meeting Nasdaq gender diversity criteria.
- Active search for candidate with diversity of skill, experience, gender, race, ethnicity, and age.
- Company aims to fill the vacancy on or before December 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123025873/0001140361-23-025873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123025873/brhc20053252_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-025873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer